Medical Journals

Indiplon is a High-affinity Positive Allosteric Modulator with Selectivity for Alpha1 Subunit-containing Gabaa Receptors.

Authors:
  • Petroski Robert E
  • Pomeroy Jordan E
  • Das Ronnie
  • Bowman Heath
  • Yang Weidong
  • Chen Adele P
  • Foster Alan C

From: Department of Neuroscience, Neurocrine Biosciences Inc., San Diego, CA 92130, USA. rpetroski@neurocrine.com

The Journal of pharmacology and experimental therapeutics

  • Publish Date: Apr 2006
  • ISSN: 0022-3565
  • Volume: 317
  • Issue: 1
  • Pages: 369-77
  • Medium: Print
  • Language: English
  • Citation (JAMA): Petroski Robert E, Pomeroy Jordan E, Das Ronnie, et al. Indiplon is a High-affinity Positive Allosteric Modulator with Selectivity for Alpha1 Subunit-containing Gabaa Receptors.. J. Pharmacol. Exp. Ther. Apr 2006;317:369-77

Abstract

Indiplon (NBI 34060) is a novel pyrazolopyrimidine currently in development for the treatment of insomnia. We have previously shown that indiplon exhibits high-affinity binding to native GABA(A) receptors from rat brain and acts as a positive allosteric modulator of GABA(A) receptor currents in cultured rat neurons (Sullivan et al., 2004). In this study, we examined the GABA(A) receptor alpha subunit selectivity of indiplon using electrophysiological techniques to record GABA-activated chloride currents from recombinant rodent GABA(A) receptors expressed in human embryonic kidney 293 cells. Indiplon potentiated the GABA-activated chloride current in recombinant GABA(A) receptors in a dose-dependent and reversible manner and was approximately 10-fold selective for alpha1 subunit-containing receptors over GABA(A) receptors containing alpha2, alpha3, or alpha5 subunits. The EC(50) values were 2.6, 24, 60, and 77 nM for alpha1beta2gamma2, alpha2beta2gamma2, alpha3beta3gamma2, and alpha5beta2gamma2 receptors, respectively. Indiplon was approximately 10 times more potent than zolpidem and zopiclone and >100 times more potent than zaleplon. Moreover, indiplon, up to 1 microM, did not potentiate GABA(A) receptors composed of alpha4beta2gamma2 and alpha6beta2gamma2 subunits. This mechanism of action is proposed to underlie the sedative-hypnotic effects of indiplon in animals and humans.

Mesh Headings (Keywords): Allosteric Regulation, Animals, Astrocytes, Benzodiazepines, Binding, Competitive, Cell Line, Cloning, Molecular, Dose-Response Relationship, Drug, Humans, Hypnotics and Sedatives, Molecular Structure, Neurons, Protein Subunits, Rats, Receptors, GABA-A, Recombinant Proteins, Thiophenes


Check for Full Text / PubMed Unique Identifier (PMID): 16399882


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.